STOCK TITAN

Amylyx: Perceptive reports 8.2% passive stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Amylyx Pharmaceuticals, Inc. (AMLX) is the issuer of the common stock covered by Amendment No. 5 to a Schedule 13G, which reports 10,573,735 shares beneficially owned by each of Perceptive Advisors LLC, Joseph Edelman and Perceptive Life Sciences Master Fund, equal to 8.2% of the class. The percentages are based on 128,562,904 shares outstanding as of October 26, 2026. The Master Fund directly holds the shares; Perceptive Advisors is its investment manager, and Edelman is the firm's managing member.

Beneficially owned shares 10,573,735 shares Reported by each of the three reporting persons for the same Master Fund position.
Ownership percentage 8.2% Reported for each reporting person.
Shares outstanding 128,562,904 shares As of October 26, 2026; basis for the reported ownership percentages.
beneficially owned regulatory
"10,573,735 shares beneficially owned"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power regulatory
"Shared Voting Power 10,573,735.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared Dispositive Power 10,573,735.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Amylyx (AMLX) shares did the reporting persons beneficially own?

The three reporting persons each reported beneficial ownership of 10,573,735 shares, representing 8.2% of the class. The reported amounts describe the same shares directly held by the Master Fund.

Who has voting and disposition power over the reported AMLX shares?

Perceptive Advisors LLC, Joseph Edelman and Perceptive Life Sciences Master Fund each reported shared voting power and shared dispositive power over 10,573,735 shares, with no sole voting or dispositive power reported.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





03237H101

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Perceptive Advisors LLC
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Member
Date:11/16/2026
Joseph Edelman
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman
Date:11/16/2026
Perceptive Life Sciences Master Fund, Ltd.
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Member
Date:11/16/2026

Keep reading